Floating Button
Home News Agriculture

Bayer gets mixed reception at US Supreme Court on Roundup suits

Greg Stohr / Bloomberg
Greg Stohr / Bloomberg • 6 min read
Bayer gets mixed reception at US Supreme Court on Roundup suits
Bayer is looking to put an end to litigation that has cost the company more than US$10 billion and depressed its stock price
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.
Add as a preferred source on Google

(April 28): The US Supreme Court gave Bayer AG a mixed reception on its bid to stop tens of thousands of lawsuits claiming its Roundup herbicide should have been labelled as a cancer risk.

Hearing arguments in Washington Monday, the justices weighed a US$1.25 million (RM4.94 million) jury verdict won by a Missouri man who blamed Roundup for his non-Hodgkin lymphoma. The company contends that since US regulators did not require a cancer warning, federal law bars the Missouri suit and others like it.

Bayer drew supportive comments from Justice Brett Kavanaugh, who questioned whether lawsuits alleging a failure to warn could be squared with a provision in federal law requiring “uniformity” in herbicide labels. But Chief Justice John Roberts suggested that states considering new evidence that a product is risky should be allowed to “call this danger to the attention of the people".

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.